Online clinical care and medication access

Hone Health review

I would consider Hone for a specific testing and follow-up need, with the relevant tier, clinician and medication costs made clear. Its catalogue is broader than a single treatment programme. I would keep each product’s evidence and purchase terms separate rather than pay for an implied combined longevity outcome.

A useful next step?

Consider the purpose, the care relationship and the full commitment.

Visit Hone HealthOfficial provider website. No affiliate relationship is currently listed.

A reason to consider it

A reader with a defined care question who can evaluate the selected tier and follow-up.

  • The support overview distinguishes tier benefits and medication exclusions.
  • Standalone async products have their own published care and price description.
  • The FAQ addresses continuing membership charges and cancellation.

What deserves scrutiny

A buyer treating all catalogue products as one evidence-backed healthy-aging package.

  • The catalogue does not establish a combined healthspan outcome.
  • A membership payment does not include every medication or test.
  • Access varies by programme, product and location.
In this review

Start with the clinical question, not the catalogue

Hone describes testing, physician consultation, a personalized plan and continuing support. Its homepage emphasizes a panel of more than fifty biomarkers. [1] I would begin with the reason for seeking that assessment: a defined symptom, a treatment question or a result that needs clinical interpretation.

More measurements do not automatically mean better decisions. Ask which findings would change care and how they will be reviewed over time. A useful clinical relationship makes the next action understandable; a broad promise to optimize longevity leaves that practical question unanswered.

The tier determines which care is being purchased

The support overview distinguishes Basic, Plus and Premium, while the main homepage highlights Basic and Premium. Basic is $25 monthly with optional paid consultations; Premium is $155 monthly and includes consults and broader follow-up. Medication is additional. [1] [2]

The overview also separates initial testing from starting treatment and notes that testing pathways affect costs. I would obtain the selected first invoice rather than infer that a membership headline covers every test or prescription. The lower tier is not automatically the appropriate tier for every medicine.

Weight care and standalone NAD are different agreements

Hone’s liraglutide page lists a compounded product from $160 monthly plus membership and labels it Premium. Its NAD page lists $199, while the async guide describes $199 without membership or a $165 member medication rate. [5] [6] [7] These should not be merged into one treatment budget or approval pathway.

The async guide says physician approval precedes payment for that route and a declined request is not charged. [7] That is a product-pathway condition, not a universal refund promise for testing or membership. Confirm which agreement applies to the actual service being considered.

A healthy-aging message is not a clinical outcome

The NAD page discusses cellular mechanisms and lifespan but acknowledges that many supporting studies are animal studies not proven in humans. [6] The liraglutide page identifies a compounded preparation that is not FDA-approved. [5] Those boundaries belong beside the commercial offer.

I would not convert testimonials, general weight-loss claims or catalogue breadth into evidence that combining products extends healthspan. Each proposed treatment needs its own clinical purpose and evidence. A testing-led service can be worth assessing without assuming every intervention in the menu improves longevity.

Ongoing access has an ongoing bill

The membership FAQ says the fee continues during months when medication is skipped and cancellation is effective at the end of the current billing period. It says medication charges require explicit approval. [3] Understand which services remain useful while a prescription is paused.

The February 24 terms describe automatic subscription renewal and nonrefundable paid fees, with a separate fifteen-day notice clause for revoking payment authorization. They also distinguish the platform from independent clinical providers and pharmacies. [9] I would clarify the actual renewal and any unfulfilled order rather than assume stopping one part ends every obligation.

My assessment stays with the defined service

The state guide gives different availability by programme, tier and men’s or women’s care. [8] It does not establish that every product is available wherever a membership is offered. Check the actual proposed service at the reader’s location.

I would shortlist Hone when the clinical question, responsible clinician, relevant tests and continuing cost are clear. Compare that arrangement with another service doing the same job. A broad catalogue should make it easier to find suitable care, not replace the explanation of why a particular treatment is appropriate.

Understanding the cost

Basic $25/month and Premium $155/month exclude medicines; optional consultations, onboarding and testing arrangements vary. Liraglutide from $160/month plus membership; NAD async $199 without membership/$165 member medication price plus membership. These are distinct offers, not a combined healthspan package or verified complete bill. [1] [2] [5] [7]

Build your cost estimate

Sources

  1. Hone homepage: current membership prices, medication exclusions and care model
  2. Hone membership overview: initial and recurring tier fees, labs and medication exclusions
  3. Hone membership FAQ: medication approval, ongoing billing and cancellation
  4. Hone current weight-care menu: named medicines and membership conditions
  5. Hone compounded liraglutide: from-price, Premium tier and nonapproval disclosure
  6. Hone NAD+ injections: current product description and evidence qualifications
  7. Hone current async-care guide: standalone NAD price, physician review and charging
  8. Hone state availability: separate programmes and location limits
  9. Hone terms revised February 24, 2026: clinical parties, subscriptions, payment authorization and refunds

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.